Revenue (Tables)

9 Months Ended

Sep. 30, 2022

Revenue From Contract With Customer [Abstract]

Schedule Of Collaboration Revenue

Revenue was as follows for the three and nine months ended September 30, 2022 and 2021:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Neurocrine Biosciences:
Recognition of the transaction price	$	—	$	823	$	372	$	1,440
Research and development services		132		2,031		1,938		4,990
Milestone payments		—		5,270		7,124		5,270
Pacira BioSciences:
Milestone payments		—		—		—		3,000
Total collaboration revenue	$	132	$	8,124	$	9,434	$	14,700